BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
After-Hours: 20:00
BioCardia Accounts Receivable (Quarterly): 0.01M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.01M |
March 31, 2024 | 0.058M |
December 31, 2023 | 0.063M |
September 30, 2023 | 0.104M |
June 30, 2023 | 0.115M |
March 31, 2023 | 0.153M |
December 31, 2022 | 0.201M |
September 30, 2022 | 0.30M |
June 30, 2022 | 0.211M |
March 31, 2022 | 0.326M |
December 31, 2021 | 0.147M |
September 30, 2021 | 0.198M |
June 30, 2021 | 0.229M |
March 31, 2021 | 0.19M |
December 31, 2020 | 0.232M |
September 30, 2020 | 0.304M |
June 30, 2020 | 0.214M |
March 31, 2020 | 0.179M |
December 31, 2019 | 0.147M |
September 30, 2019 | 0.103M |
June 30, 2019 | 0.204M |
March 31, 2019 | 0.287M |
December 31, 2018 | 0.274M |
September 30, 2018 | 0.17M |
June 30, 2018 | 0.191M |
Date | Value |
---|---|
March 31, 2018 | 0.127M |
December 31, 2017 | 0.095M |
September 30, 2017 | 0.09M |
June 30, 2017 | 0.142M |
March 31, 2017 | 0.121M |
December 31, 2016 | 0.074M |
September 30, 2016 | |
June 30, 2016 | 0.142M |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | 0.024M |
June 30, 2012 | 0.024M |
March 31, 2012 | 0.024M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.01M
Minimum
Jun 2024
0.326M
Maximum
Mar 2022
0.1742M
Average
0.1845M
Median
Accounts Receivable (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 309.48M |
Theriva Biologics Inc | -- |
Zevra Therapeutics Inc | 8.947M |
PetIQ Inc | 214.98M |
Instil Bio Inc | -- |